Invivyd (IVVD) Depreciation & Amortization (CF) (2021 - 2025)

Invivyd (IVVD) reported Depreciation & Amortization (CF) of $149000.0 for Q4 2025, down 86.25% on a YoY basis from $1.1 million in Q4 2024, and little changed quarter-over-quarter from $149000.0 in Q3 2025.

Invivyd (IVVD) Depreciation & Amortization (CF) (2021 - 2025) Analysis & Trends

Invivyd has reported Depreciation & Amortization (CF) for 5 years, with the latest figure at $149000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 86.25% year-over-year to $149000.0; the trailing twelve-month figure through Dec 2025 stood at $755000.0 (down 48.5% YoY), and the FY2025 full-year result was $755000.0, down 48.5% from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 stood at $149000.0, roughly flat from $149000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $1.1 million in Q4 2024, with the low at $1000.0 in Q4 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $161352.9 across 5 years, with a median of $121000.0 in 2023.
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) soared 2900.0% — and 2025, when it sank 86.25%.
  • Invivyd's Depreciation & Amortization (CF) stood at $1000.0 in 2021, then surged by 2600.0% to $27000.0 in 2022, then surged by 344.44% to $120000.0 in 2023, then surged by 803.33% to $1.1 million in 2024, then slumped by 86.25% to $149000.0 in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at $149000.0 (Q4 2025), $149000.0 (Q3 2025), and $151000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1,395.22
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1,330.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 429,663.65
10 Invivyd 168.41 Mn -58.28 Mn - 149,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 149,000.00
Dec 31, 2025 149,000.00
Sep 30, 2025 149,000.00
Sep 30, 2025 149,000.00
Jun 30, 2025 151,000.00
Jun 30, 2025 151,000.00
Mar 31, 2025 306,000.00
Mar 31, 2025 306,000.00
Dec 31, 2024 1.08 Mn
Dec 31, 2024 1.08 Mn
Sep 30, 2024 132,000.00
Sep 30, 2024 132,000.00
Jun 30, 2024 128,000.00
Jun 30, 2024 128,000.00
Mar 31, 2024 122,000.00
Mar 31, 2024 122,000.00
Dec 31, 2023 120,000.00
Dec 31, 2023 120,000.00
Sep 30, 2023 119,000.00
Sep 30, 2023 119,000.00